Rani Therapeutics Holdings, Inc. (RANI)
0.6406
-0.04
(-5.79%)
USD |
NASDAQ |
Oct 16, 16:00
0.6392
0.00 (0.00%)
After-Hours: 20:00
Rani Therapeutics Holdings Price to Book Value : 1.837 for Oct. 16, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 16, 2026 | 1.837 |
| October 15, 2026 | 1.950 |
| October 14, 2026 | 1.922 |
| October 13, 2026 | 2.102 |
| October 12, 2026 | 2.153 |
| October 09, 2026 | 2.291 |
| October 08, 2026 | 2.271 |
| October 07, 2026 | 2.329 |
| October 06, 2026 | 2.376 |
| October 05, 2026 | 2.222 |
| October 02, 2026 | 2.325 |
| October 01, 2026 | 2.281 |
| September 30, 2026 | 2.268 |
| September 29, 2026 | 2.295 |
| September 28, 2026 | 2.225 |
| September 25, 2026 | 2.177 |
| September 24, 2026 | 2.148 |
| September 23, 2026 | 2.199 |
| September 22, 2026 | 2.230 |
| September 21, 2026 | 2.264 |
| September 18, 2026 | 2.472 |
| September 17, 2026 | 2.442 |
| September 16, 2026 | 2.168 |
| September 15, 2026 | 2.356 |
| September 14, 2026 | 2.397 |
| Date | Value |
|---|---|
| September 11, 2026 | 2.416 |
| September 10, 2026 | 2.357 |
| September 09, 2026 | 2.409 |
| September 08, 2026 | 2.502 |
| September 04, 2026 | 2.481 |
| September 03, 2026 | 2.444 |
| September 02, 2026 | 2.460 |
| September 01, 2026 | 2.479 |
| August 31, 2026 | 2.448 |
| August 28, 2026 | 2.409 |
| August 27, 2026 | 2.449 |
| August 26, 2026 | 2.413 |
| August 25, 2026 | 2.555 |
| August 24, 2026 | 2.520 |
| August 21, 2026 | 2.523 |
| August 20, 2026 | 2.440 |
| August 19, 2026 | 2.628 |
| August 18, 2026 | 2.367 |
| August 17, 2026 | 2.282 |
| August 14, 2026 | 2.283 |
| August 13, 2026 | 2.288 |
| August 12, 2026 | 2.302 |
| August 11, 2026 | 2.251 |
| August 10, 2026 | 2.228 |
| August 07, 2026 | 2.271 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 13.47 |
| CNBX Pharmaceuticals, Inc. | -- |
| Arvinas, Inc. | 0.8096 |
| Fulcrum Therapeutics, Inc. | 0.8962 |
| Definium Therapeutics, Inc. | 4.695 |
Price to Book Value Related Metrics
| PS Ratio | 18.41 |
| Price | 0.6406 |
| Earnings Yield | -41.40% |
| Market Cap | 72.07M |